The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function.


Updates from The Motley Fool

Latest updates on Illumina from Fool.com.  The Fool has written over 200 articles on Illumina.
Can Illumina Regain Its Mojo?

Image source: Getty Images. For Illumina (NASDAQ: ILMN) investors, the summer of 2015 represent...

3 Biotech Stocks to Buy on Sale

Image source: Getty Images. You know what makes long-term investing even sweeter? Buying great co...

Illumina, Inc. in 3 Charts

Image source: Illumina. In 1990, the U.S. government gave the green light to the Human Genome Pro...

Is It Time To Buy Illimuna Again?

Image Source: Illumina, Inc. After warning about disappointing first quarter results in April,  I...



Stock Performance

View Interactive ILMN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Illumina.
Current Price: $123.20
Prev Close: $123.48
Open: $123.82
Bid: $120.03
Ask: $124.50
Day's Range: $122.96 - $128.78
52wk Range: $119.37 - $196.47
Volume: 1,387,993
Avg Vol 1,497,680
Market Cap: $18B
P/E (ttm): 41.44
EPS (ttm): $2.98
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Illumina.
CAPS Rating 5 out of 5
 
1094 Outperform
53 Underperform
CAPS All Stars
 
269 Outperform
13 Underperform

How do you think Illumina will perform against the market?



You pick for Illumina is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Francis deSouza, CEO

86% Approve

Based on 37 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Illumina.

The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers